- Filed
- Feb 18, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2020 · Dec 31, 2020 | 8.14M sh |
| Shares Diluted | Q1 2020 · Dec 31, 2019 | 8.14M sh |
| Operating Cash Flow | Q1 2020 · Dec 31, 2020 | −$321.7K |
| Operating Cash Flow | Q1 2020 · Dec 31, 2019 | $117.19K |
| Cash And Equivalents | Q1 2020 · Dec 31, 2020 | $271.45K |
| Cash And Equivalents restated | Q1 2020 · Sep 30, 2020 | $429.82K |
| Cash And Equivalents | Q1 2020 · Jun 30, 2020 | $429.82K |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $429.82K |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $612.07K |
| Cash And Equivalents restated | Q1 2020 · Sep 30, 2019 | $506.62K |
| Cash And Equivalents restated | Q1 2020 · Jun 30, 2019 | $506.62K |
| Cash And Equivalents restated | Q1 2020 · Mar 31, 2019 | $506.52K |
| Stockholders Equity | Q1 2020 · Dec 31, 2020 | $1.22M |
| Stockholders Equity | Q1 2020 · Mar 31, 2020 | $1.23M |
| Current Liabilities | Q1 2020 · Dec 31, 2020 | $49.52K |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $99.86K |
| Current Assets | Q1 2020 · Dec 31, 2020 | $490.7K |
| Current Assets | Q1 2020 · Mar 31, 2020 | $643.77K |
| Total Assets | Q1 2020 · Dec 31, 2020 | $1.27M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $1.33M |
| Sga Expense | Q1 2020 · Dec 31, 2020 | $25.05K |
| Sga Expense restated | Q1 2020 · Dec 31, 2019 | $42.69K |
| Rd Expense | Q1 2020 · Dec 31, 2020 | $14.06K |
| Rd Expense restated | Q1 2020 · Dec 31, 2019 | $18.21K |
| Net Income | Q1 2020 · Dec 31, 2020 | −$506K |
| Net Income | Q1 2020 · Dec 31, 2019 | −$12.09K |
| Cost Of Revenue | Q1 2020 · Dec 31, 2020 | −$11.98K |
| Cost Of Revenue restated | Q1 2020 · Dec 31, 2019 | −$14.07K |
| Capex | Q1 2020 · Dec 31, 2019 | −$6.23K |